In the Phase 2 clinical trial, participants generally met the following criteria: Body mass index (BMI) of 27 kg/m or above with at least one weight-related comorbidity (such as hypertension, dyslipidaemia, or obstructive sleep apnoea), or a BMI of 30 kg/m or above without comorbidities
Glucagon signaling may influence energy expenditure and liver-related metabolism
But if you take warfarin, you should be particularly careful when it comes to drinking, notes the American Heart Association, as alcohol can affect how the drug is metabolized
Splitting or Crushing: Why You Must Swallow the Tablet Whole While an effective barrier, the SNAC technology that protects oral GLP-1s is delicate
What Is Retatrutide (GLP-3)
The following table summarizes pipeline timelines and phases for the specified companies as of March 2026